Citation Impact
Citing Papers
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Hematocrit Level and Associated Mortality in Hemodialysis Patients
1999
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
Optimal Choice of Dialysis Access for Chronic Kidney Disease Patients: Developing a Life Plan for Dialysis Access
2012
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Biosimilar epoetins and other “follow‐on” biologics: Update on the European experiences
2010
Comparison of Mortality Between Private For-Profit and Private Not-For-Profit Hemodialysis Centers
2002
What is “quality of evidence” and why is it important to clinicians?
2008 Standout
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Mortality Risk by Hemodialyzer Reuse Practice and Dialyzer Membrane Characteristics: Results From the USRDS Dialysis Morbidity and Mortality Study
2001
Anemia, chronic renal disease and congestive heart failure—the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists
2006
Microbiology and outcomes of peritonitis in North America
2006
Chronic kidney disease
2011 Standout
Determinants of Compliance Behaviours among Patients Undergoing Hemodialysis in Malaysia
2012 Standout
Anemia management and outcomes from 12 countries in the dialysis outcomes and practice patterns study (DOPPS)
2004
Self‐reported adherence to a therapeutic regimen among patients undergoing continuous ambulatory peritoneal dialysis
2010
Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy
2004
Cardiorenal Syndrome
2008 Standout
History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology
2017 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
The impact of education on chronic kidney disease patients' plans to initiate dialysis with self-care dialysis: A randomized trial
2005
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
2002 Standout
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis
2015 Standout
Complications of Progression of CKD
2011
Comparison of Intravenous Iron Sucrose to Oral Iron in the Treatment of Anemic Patients with Chronic Kidney Disease Not on Dialysis
2005
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Mortality by Dialysis Modality among Patients Who Have End-Stage Renal Disease and Are Awaiting Renal Transplantation
2006
Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis
2005
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences
2003 Standout
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
2017 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death
2015 Standout
Anemia of Chronic Disease
2005 Standout
Hydroxychloroquine in Patients with Systemic Lupus Erythematosus with End-Stage Renal Disease
2016
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
2005 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Choosing dialysis modality: decision making in a chronic illness context
2012
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Focal segmental glomerulosclerosis in adults
2003
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Comparative Survival of Dialysis Patients in the United States After Coronary Angioplasty, Coronary Artery Stenting, and Coronary Artery Bypass Surgery and Impact of Diabetes
2002
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Long-Term Survival of Dialysis Patients in the United States With Prosthetic Heart Valves
2002
Works of Susan Everson being referenced
Peritoneal and hemodialysis: II. Mortality risk associated with initial patient characteristics
2002
Impact of disease severity and hematocrit level on reuse-associated mortality
2000
Mortality risks of peritoneal dialysis and hemodialysis
1999
Peritoneal and hemodialysis: I. Differences in patient characteristics at initiation
2002
Anemia treatment in the pre-ESRD period and associated mortality in elderly patients
2002
Dialysis unit and patient characteristics associated with reuse practices and mortality
1998